Pharma’s ‘Value Delivery System’ Still Tuned To A Self-serving Mode?

Just as any other industry, pharma business is also primarily a ‘value delivery system.’ Its each and every employee need to understand and internalize this basic philosophy of the business. This organizational mindset needs to be created by the very … Continue reading

‘Unbossing’ Pharma Culture For Millennials – A Sine Qua Non For Future Growth

Wishing All My Readers A Very Happy, Healthy, Peaceful and Prosperous 2019 ‘Unbossing’ an organizational culture is an interesting idea – more in the context of promoter driven Indian drug companies of all sizes and scale. The word – ‘unboss’ is … Continue reading

The Importance of Managing ‘Perception’ in Pharma

Each one of us – individually or collectively in a society, community or even as a supporter of anyone or anything, view certain things in a certain way, and tend to believe only this is true. This process consequently leads … Continue reading

Creating ‘Shared Value’ in Pharma – The Way Forward

Many Pharmaceutical companies, both global and local, are struggling with a plethora of critical challenges. With the industry reputation diving south successful navigation through this headwind has become an onerous task, more than ever before. Under this backdrop, the article, … Continue reading

Creating A ‘Virtuous Cycle’ Through Patient Reach and Care

As many would know, in the strategic marketing process of any product including patented and generic drugs crafty product differentiation plays a critical role. This strategic process of creating a competitive edge with unique product differentials is necessary. It helps perceiving … Continue reading

With ‘Cutting Corners’ Going North, Pharma Reputation Dives South

Just a few months ago, on October 24, 2017, ‘New Jersey Law Journal’ came out with an eye-catching headline – “Sanofi Set to Pay $ 61M Settlement in Antitrust Suit Over Vaccine Bundling.” The suit says: “Sanofi-Pasteur allegedly suppressed competition … Continue reading

Pharma ‘To Endeavor More To Be What It Desires To Appear’

Reputation is one of the most fundamental requirements for long-term sustainability of any business, without facing too much of avoidable distraction, or even a tough headwind from any hostile business environment. This fact is, of course, no-brainer. We all know … Continue reading

Dwindling Drug Innovation: Declining Image: Unchanged Business And Advocacy Models

A report of ‘The United States International Trade Commission (USITC)’ released on December 22, 2014 suggested, if tariffs and investment restrictions were fully eliminated, and standards of IP protection were made comparable to the U.S and Western European levels, American … Continue reading